Skip to main content

Advertisement

Log in

A deep learning system for predicting time to progression of diabetic retinopathy

  • Research Briefing
  • Published:

From Nature Medicine

View current issue Submit your manuscript

We developed and validated a deep learning system (termed DeepDR Plus) in a diverse, multiethnic, multi-country dataset to predict personalized risk and time to progression of diabetic retinopathy. We show that DeepDR Plus can be integrated into the clinical workflow to promote individualized intervention strategies for the management of diabetic retinopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: DeepDR Plus predicts DR time to progression.

References

  1. Wong, T. Y. et al. Diabetic retinopathy. Nat. Rev. Dis. Primers 2, 16012 (2016). A review article that discusses DR epidemiology, pathophysiology, diagnosis, and treatment options, as well as its effect on quality of life.

    Article  PubMed  Google Scholar 

  2. Stratton, I. M. et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia 44, 156–163 (2001). This paper reports the high variability in risk of DR progression and the need for good glycemic control and assiduous treatment of hypertension.

    Article  CAS  PubMed  Google Scholar 

  3. Bora, A. et al. Predicting the risk of developing diabetic retinopathy using deep learning. Lancet Digit. Health 3, e10–e19 (2021). This paper reports a deep learning system for predicting DR development from fundus images, which are independent of and more informative than available risk factors.

    Article  CAS  PubMed  Google Scholar 

  4. Liu, H. et al. Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis. Lancet Glob. Health 11, e456–e465 (2023). This paper reports that AI coupled with teleophthalmology is cost-effective in both rural and urban China, which presents an opportunity to promote equity in eye health.

    Article  CAS  PubMed  Google Scholar 

  5. Rajpurkar, P. et al. AI in health and medicine. Nat. Med. 28, 31–38 (2022). A review article that presents the advances, challenges and potential in the field of medical AI.

    Article  CAS  PubMed  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Dai, L. et al. A deep learning system for predicting time to progression of diabetic retinopathy. Nat. Med. https://doi.org/10.1038/s41591-023-02702-z (2024).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

A deep learning system for predicting time to progression of diabetic retinopathy. Nat Med 30, 358–359 (2024). https://doi.org/10.1038/s41591-023-02742-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-023-02742-5

  • Springer Nature America, Inc.

Navigation